Citius Pharmaceuticals (CTXR) Stock Forecast & Price Target

$0.13 -0.03 (-18.32%)

(As of 11/22/2024 ET)

Citius Pharmaceuticals - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Strong Buy

Based on 2 Analyst Ratings

Sell
0

Hold
0

Buy
2

Based on 2 Wall Street analysts who have issued ratings for Citius Pharmaceuticals in the last 12 months, the stock has a consensus rating of "Strong Buy." Out of the 2 analysts, 1 has given a buy rating, and 1 has given a strong buy rating for CTXR.

Consensus Price Target

$4.00
2,889.54% Upside

According to the 2 analysts' twelve-month price targets for Citius Pharmaceuticals, the average price target is $4.00. The highest price target for CTXR is $4.00, while the lowest price target for CTXR is $4.00. The average price target represents a forecasted upside of 2,889.54% from the current price of $0.13.

Get the Latest News and Ratings for CTXR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Citius Pharmaceuticals and its competitors.

CTXR Analyst Ratings Over Time

Type	Current Forecast 11/24/23 to 11/23/24	1 Month Ago 10/25/23 to 10/24/24	3 Months Ago 8/26/23 to 8/25/24	1 Year Ago 11/24/22 to 11/24/23
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	1 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$4.00	$4.00	$4.00	$4.00
Forecasted Upside	2,889.54% Upside	1,056.07% Upside	572.27% Upside	406.39% Upside
Consensus Rating	Strong Buy	Strong Buy	Strong Buy	Buy

I hate to say I told you so (Ad)

Last month, I openly declared that a Trump Presidency was going to kick off Tesla’s New Bullish Cycle Folks who listened and bought in when I said to are currently crushing it. As a matter of fact, all the trades we’ve opened ever since I made that public declaration have ALL been winners. And it’s simply because this Tesla indicator just flipped green on the stock…

Follow this link right away.

CTXR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CTXR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Citius Pharmaceuticals Stock vs. The Competition

Type	Citius Pharmaceuticals	Medical Companies	S&P 500
Consensus Rating Score	3.50	2.80	2.50
Consensus Rating	Strong Buy	Moderate Buy	Moderate Buy
Predicted Upside	2,889.54% Upside	26,878.78% Upside	7.66% Upside
News Sentiment Rating	Neutral News See Recent CTXR News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date	Details
11/12/2024	HC Wainwright 2 of 5 stars		Reiterated Rating	Buy ➝ Buy	$4.00 ➝ $4.00	+790.45%
7/15/2024	EF Hutton Acquisition Co. I 1 of 5 stars	J. Kolbert Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 06:38 AM ET.

CTXR Forecast - Frequently Asked Questions

: According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for Citius Pharmaceuticals is $4.00, with a high forecast of $4.00 and a low forecast of $4.00.
: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Citius Pharmaceuticals in the last year. There is currently 1 buy rating and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "strong buy" CTXR shares.
: According to analysts, Citius Pharmaceuticals's stock has a predicted upside of 2,889.54% based on their 12-month stock forecasts.
: Citius Pharmaceuticals has been rated by research analysts at HC Wainwright in the past 90 days.
: Analysts like Citius Pharmaceuticals more than other "medical" companies. The consensus rating for Citius Pharmaceuticals is Strong Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CTXR compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

I hate to say I told you so (Ad)

Follow this link right away.

This page (NASDAQ:CTXR) was last updated on 11/23/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Citius Pharmaceuticals (CTXR) Stock Forecast & Price Target